Discover Tenders by Plasma Extracts Sector

Find the most relevant tenders for Plasma Extracts. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Plasma Extracts tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Plasma Extracts tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Vancomycin In The Dosage Form Hkp

Deadline: 10 May 2027

Germany

Ref. No.: 21631660

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Trimethoprim Sulfamethoxazole Co Trimoxazole In The Dosage Form Tab

Deadline: 10 May 2027

Germany

Ref. No.: 21631645

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Active Ingredient Combination Risedronic Acid Ca Colecalciferol With The Atc Code M05Bb04

Deadline: 10 May 2027

Germany

Ref. No.: 21631633

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Phenoxymethylpenicillin In The Dosage Forms Fta And Tab

Deadline: 10 May 2027

Germany

Ref. No.: 21631624

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Omeprazole As An Otc Medicine

Deadline: 10 May 2027

Germany

Ref. No.: 21631600

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Octreotide In The Dosage Forms Pls And Trs

Deadline: 10 May 2027

Germany

Ref. No.: 21631585

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Moxifloxacin In The Dosage Form Atr

Deadline: 10 May 2027

Germany

Ref. No.: 21631572

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Metoprolol In The Dosage Form Ret And The Effective Strength 50Mg

Deadline: 10 May 2027

Germany

Ref. No.: 21631557

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lopinavir Ritonavir In The Dosage Form Fta

Deadline: 10 May 2027

Germany

Ref. No.: 21631539

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Lercanidipine

Deadline: 10 May 2027

Germany

Ref. No.: 21631528

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Isosorbide Mononitrate The Dosage Forms Ret Rek And Selected Strengths

Deadline: 10 May 2027

Germany

Ref. No.: 21631517

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ipratropium Bromide

Deadline: 10 May 2027

Germany

Ref. No.: 21631503

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ibuprofen In The Dosage Form Fta And From An Effective Strength Of 400 Mg As An Otc Medication

Deadline: 10 May 2027

Germany

Ref. No.: 21631490

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Glatiramer Acetate In The Dosage Form Pen And From An Effective Strength Of 40 Mg Ml

Deadline: 10 May 2027

Germany

Ref. No.: 21631477

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Fluticasone In The Dosage Form Ihp And From An Effective Strength Of 0 25 Mg

Deadline: 10 May 2027

Germany

Ref. No.: 21631465

EMD:Ref Document

Bid Value: Ref Document

496 Days Left

Showing 1801 to 1815 of 2579 results

Discover Tenders by Plasma Extracts Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Plasma Extracts Sector

Filter Your Search

FREE Trial plan for all new users!